Cancer care is entering a defining moment. As data volumes grow and clinical complexity increases, artificial intelligence is no longer a future promise – it is becoming a practical force reshaping how oncology is delivered. Across Europe and beyond, AI is moving from experimentation to real-world impact, helping clinicians diagnose earlier, personalise treatments, and improve outcomes for patients.
This transformation is unfolding within a rapidly expanding landscape. By 2030, AI-enabled healthcare represents a €169 billion opportunity, with oncology emerging as one of its most dynamic frontiers. But growth alone does not define success. The real differentiator lies in how insight is translated into action – and how innovation is scaled responsibly, transparently, and with trust at its core.
At the centre of this shift is a simple truth: technology alone is not enough. Meaningful change happens when data, strategy, funding, and governance move in alignment. The organisations shaping the future of oncology are those that connect evidence with execution, transforming research excellence into measurable value for healthcare systems and patients alike.
Developed by PNO Innovation, this teaser brings together market intelligence, policy awareness, and hands-on experience from Europe’s oncology innovation ecosystem. Drawing on initiatives such as ONCOVALUE and other leading collaborations, it offers a clear, grounded view of how AI is already enhancing early detection, streamlining imaging analysis, and supporting more precise, value-driven clinical decisions.
Authored by Chandra Gracia Anweta, Chiara Zocchi, and Martha Gilbert, the teaser reflects PNO Innovation’s multidisciplinary approach – bridging research, funding, regulation, and implementation. Their analysis highlights how collective intelligence, shared infrastructure, and coordinated policy are becoming Europe’s strategic advantage in shaping the global future of oncology.
Looking ahead, the next phase of leadership in oncology will belong to those who can operationalise intelligence while remaining ready for evolving regulatory and ethical expectations. Responsible AI adoption is no longer a constraint; it is a catalyst for credibility, resilience, and long-term impact. The future of oncology will be defined not just by smarter algorithms, but by smarter choices about how innovation is designed, deployed, and governed.
Explore the teaser and discover how PNO Innovation is helping turn data-driven insight into enduring value, advancing precision, performance, and trust in cancer care.